A.J. Minter's Comeback Hits Another Wall, and the Mets' Bullpen Depth Takes the Hit

A.J. Minter's return to the Mets' bullpen has been pushed back indefinitely after the left-hander reported left hip discomfort following a May 3 Triple-A outing, per the team's announcement. New York pulled him off his rehab assignment — which had been set to expire Friday, meaning activation was imminent — and will instead give him a few days of rest before restarting a throwing program. The Mets now have a fresh 30-day rehab clock available, and there is no clear timeline for when Minter will rejoin the major league roster.

The timing stings on multiple levels. Minter has been working back from a left lat tear suffered on April 26, 2025 — a 13-month-old injury that required surgery and a deliberately slow spring buildup. The plan was to have him ready by late April or early May 2026, and on paper the rehab looked clean: a 1.17 ERA across eight minor league appearances. But the velocity never came back fully. Minter sat in the low-90s throughout the assignment, topping out at 91.9 mph in his last outing for Triple-A Syracuse. Before the lat injury, he was a high-leverage weapon for the Braves over seven seasons, posting a 3.28 ERA and holding left-handed hitters to a .602 OPS. The gap between that version of Minter and what Syracuse was seeing is real, and now a hip that previously required labrum surgery in 2024 is adding another variable. Manager Carlos Mendoza said the organization isn't panicking, but acknowledged he doesn't yet know whether the hip discomfort was suppressing Minter's velocity all along.

The financial stakes are significant. The Mets committed two years and $22 million to Minter before last season and have received 11 innings of output. That contract math was already brutal; this setback makes it worse. With Minter out, Brooks Raley remains the primary left-handed option in the bullpen. Sean Manaea, also a southpaw, has been deployed mostly in low-leverage situations. Neither profile suggests the Mets have a true high-leverage lefty available, which is a structural gap against left-heavy lineups.

For bettors, the Mets' bullpen construction matters most in the context of their team totals and opponent run-environment against left-handed-heavy lineups. Without a reliable late-inning lefty specialist, opposing managers can stack lineups and force Mendoza into uncomfortable matchup decisions in the sixth through eighth innings. That pressure point inflates run expectation in close games. Mets team totals have been averaging around 4.0–4.5 this season, and while tonight's number depends on the starter, any game that goes deep into the bullpen — particularly against a lineup built to punish left-handed pitching — tilts toward over value on the opponent's side. Watch the opposing team total, not just the Mets' number.

The NRFI and first-five-innings markets aren't directly impacted here since Minter is a reliever, but late-inning exposure is real. If the Mets are in a one-run game in the seventh with a lefty-heavy lineup due up, the absence of a trustworthy left-handed option is a matchup edge the market may not be fully pricing. Track Mets bullpen deployment closely over the next two to three weeks — this is the window where Raley overuse or mismatches could compound into real run-prevention problems.